Imugene’s presence is felt on many marketing mediums, reaching out to a diverse target audience:
- TV
- Radio
- Youtube
- Podcasts
- Social Media
- Oncology Conferences
- JP Morgan Conference
- Directly talking to Big Pharma/Biotech
But above all else, data obtained in actual clinical trials will do the ultimate talking.
“I think we’re getting that important data where we’re making a huge stride in the biotech and pharmaceutical world and contending with the likes of other large biotech companies” - Leslie Chong, 2022
“2023 is going to be even more heavy in conferences which I’m very proud of because you need to show off your products in the world stage of cancer” - Leslie Chong, 2022
Imugene’s presence is felt on many marketing mediums, reaching...
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
8.2¢ |
Change
-0.003(3.53%) |
Mkt cap ! $600.2M | |||
| Open | High | Low | Value | Volume |
| 8.5¢ | 8.6¢ | 8.2¢ | $1.246M | 14.84M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 446526 | 8.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.3¢ | 535664 | 2 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
8.2¢ |
Change
-0.003 ( 2.38 %) |
||||
| Open | High | Low | Volume | ||
| 8.6¢ | 8.6¢ | 8.2¢ | 4518456 | ||
| Last updated 15.57pm 03/05/2024 ? | |||||
| IMU (ASX) Chart |